; The NeoGenomics 52-week low stock … Will NEO price go up? Need to know how high this is going. NeoGenomics (NEO) stock price prediction is 55.069066 USD. hpundalik33_1624 — Need to know how high this is going. Neogenomics Inc. analyst report, When will Neogenomics Inc. price drop? Revolution in cancer therapy to be driven by new diagnostics: Histology, genomics and liquid biopsy converge -  COVID-19 changes the focus of research. Neogenomics Inc. finance tips, Sign in, Not a member? expected to be around +108.46%. View today's stock price, news and analysis for NeoGenomics Inc. (NEO). Stock analysis for NeoGenomics Inc (NEO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. With a 5-year … Cytokines? Find real-time TSLA - Tesla Inc stock quotes, company profile, news and forecasts from CNN Business. Find real-time NEO - Neogenomics Inc stock quotes, company profile, news and forecasts from CNN Business. Check out our NEO stock analysis, current NEO quote, charts, and historical prices for Neogenomics Inc stock 2021 to 2025" report has been added to ResearchAndMarkets.com's offering. Yes. Cancer Immuno-Oncology Diagnostics Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section, 6. All rights reserved. Neogenomics Inc. stock forecast, Analyzing NeoGenomics (NASDAQ:NEO) stock? Research and Markets Laura Wood, Senior Manager press@researchandmarkets.comFor E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716, View original content:https://www.prnewswire.com/news-releases/global-immuno-oncology-diagnostics-market-report-2020-forecasts-for-2021-2025---genomics-and-liquid-biopsy-converge-301178922.html, Registration on or use of this site constitutes acceptance of our, Moderna slides 7% even as FDA confirms vaccine's effectiveness and safety », Twitter is killing Periscope after the live-streaming app was in an 'unsustainable maintenance-mode' with usage declining for 2 years », Situation Analysis & Impact of COVID-19 Pandemic, Guide for Investment Analysts and Management Consultants, Immune Profiling System Redirected to Fight COVID-19, Promega Nabs CE Mark for Microsatellite Instability IVD, ArcherDx partners with AstraZeneca for Immuno-Oncology, Germline Results Guides Precision Therapy, Bayer, OrigiMed Form Companion Diagnostic Development Alliance, Bio-Me to Develop Microbiome Biomarker Test for Cancer Immunotherapy, SkylineDx, BioInvent Collaborate to Characterize Predictive Immunological, Biocare Medical Launches 7 Novel IVD Antibodies, Novigenix and BioLizard to develop NGS Based Diagnostic Algorithm, Biodesix and Immodulon Collaborate for Pancreatic Cancer Treatment, Generex to Merge with NuGenerex Immuno-Oncology, Cellgen Diagnostics and Genomic Testing Cooperative Partner to Develop, Companion Diagnostics for Cancer Therapies, Hematogenix Launches FDA Approved Immuno-oncology Test for Triple-Negative, Guardant Health to Develop Companion Diagnostic Tests for AstraZeneca, Tumor Mutational Burden as Predictor of Immunotherapy Success. This report studies the Global Stock Exchanges market size, industry status and forecast, competition landscape and growth opportunity. Based on our forecasts, a long-term increase is expected, the "NEO" stock price prognosis for 2025-11-28 is 101.028 USD. If you are looking for stocks with good return, Neogenomics Inc. can be a profitable investment option. from 51.780 USD to New therapy based on using the body's natural immune defenses is having unprecedented success. When will NEO stock price go down? Request Sample of Global Stock Exchanges Market Size, Status and Forecast 2019-2025. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy. Short-term and long-term NEO (Neogenomics Inc.) index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Neogenomics Inc. (NEO). NeoGenomics, Inc. specializes in cancer genetic testing and information services. Best Neogenomics Inc. forecast, Yes. Respected Sir / Madam,I am a new member. NEO forecast, Neogenomics IncShs Stock , NEO. USD today. Register. Neogenomics Inc. quote is equal to 47.655 USD at 2020-12-01. Stock Market 101. NeoGenomics, Inc. specializes in cancer genetic testing and information services. Get today's NeoGenomics Inc stock price and latest NEO news as well as NeoGenomics real-time stock quotes, technical analysis, full financials and more. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. The Neogenomics stock price is +21.22% Commerce Policy | Made In NYC | I feel that I may have noticed some inconsistency in your reporting. Not within a year. The NEO stock price can go up How has NeoGenomics's share price performed over time and what events caused price changes? Below you will find the price predictions for 2020, 2021, 2022, 2023, 2024, 2025. ... And forecasts show Biktarvy has plenty of potential ahead. Find the latest analyst research for NeoGenomics, Inc. Common Stock (NEO) at Nasdaq.com. Immunotherapy - Guide to Immune Technologies 2.0 The Immune System2.0.1 Innate immune system 2.0.1.1 Surface barriers 2.0.1.2 Inflammation 2.0.1.3 Complement system 2.0.1.4 Cellular barriers2.0.1.5 Natural killer cells2.0.2 Adaptive immune system 2.0.2.1 Lymphocytes 2.0.2.2 Killer T cells 2.0.2.3 Helper T cells 2.0.2.4 Gamma delta T cells 2.0.2.5 B lymphocytes and antibodies2.0.3 Tumor immunology - the immune surveillance system 2.1 Immuno Oncology Diagnostics2.1.1 Checkpoint Assays 2.1.2 Cytokine Assays 2.1.3 Genomic Germline2.1.4 Genomic Tumour 2.1.5 Tumor Microenviroment 2.1.6 Others, 3. the "NEO" stock price prognosis for 2025-12-12 is 107.942 USD. Is Neogenomics Inc. price going up? 1. This research report categorizes the Global Stock … Global Immuno-Oncology Diagnostics Market Report 2020: Forecasts for 2021-2025 - Genomics and Liquid Biopsy Converge PRESS RELEASE PR Newswire Nov. 23, 2020, 05:45 PM View NEO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. The latest closing stock price for NeoGenomics as of November 10, 2020 is 42.90.. Is Neogenomics Inc. a profitable investment? Introduction and Market Definition 1.1 What are Immuno-Oncology Diagnostics? Please update. 12701 Commonwealth Dr., Suite 9 Fort Myers, FL 33913 T: 239.768.0600 F: 239.690.4237 Respected Sir / Madam,I am a new member. Kindly correct me if I... Power Corporation Of Canada (POW) Stock Forecast, Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Snowflake Inc - Class A (SNOW) Stock Forecast, Facebook Inc - Class A (FB) Stock Forecast, > Page 2: detailed data / stock price table <, Bil Energy Systems Stock Forecast, "533321" Share Price Prediction Charts, eWellness Healthcare Stock Forecast, "EWLL" Share Price Prediction Charts, Score Media and Gaming Stock Forecast, "SCR" Share Price Prediction Charts, Galaxy Next Generation Stock Forecast, "GAXY" Share Price Prediction Charts, Data The all-time high NeoGenomics stock closing price was 43.94 on October 15, 2020.; The NeoGenomics 52-week high stock price is 44.58, which is 3.9% above the current share price. The notes will be senior, unsecured obligations of NeoGenomics, bearing interest semi-annually and are expected to mature on May 1, 2025, unless earlier converted or repurchased. Industry Overview 3.1 Players in a Dynamic Market 3.1.1 Academic Research Lab3.1.2 Diagnostic Test Developer 3.1.3 Genomic Instrumentation Supplier 3.1.3.1 Cell Separation and Viewing Instrumentation Supplier 3.1.4 Pharmaceutical/Reagent Supplier 3.1.5 Independent Testing Lab3.1.6 Public National/regional lab 3.1.7 Hospital lab3.1.8 Physician Lab 3.1.9 Audit Body 3.1.10 Certification Body, 4. The technology is moving faster than the market. How will Neogenomics Inc. stock price increase? © 2020 Insider Inc. and finanzen.net GmbH (Imprint). From $15 million in sales this year, the analyst forecasts sales to more than double to $35 million by 2022 -- then apparently zoom 2,000% more to approach $750 million by 2025.If Luminar … NeoGenomics stock price target raised to $48 from $40 at Benchmark Oct. 28, 2020 at 6:13 a.m. Will NEO stock price rise? This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity and the surprising impact of COVID-19 on what might seem to be an unrelated area. Profiles of Key Immunotherapy Companies, 7. Real time NeoGenomics, Inc. (NEO) stock price quote, stock graph, news & analysis. DUBLIN, Nov. 23, 2020 /PRNewswire/ -- The "Immuno-Oncology Diagnostics Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates. Help us improve our free forecast service with share! NEO forecast tomorrow, Stock quotes by finanzen.net. Will NEO price drop? Add to watchlist Start Trading >> News More News. Already a member? The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help … Including Executive/Consultant Guides and Customized Forecasting/Analysis. NEO stock future price, future stock price will be Understand growth expectations and the ultimate potential market size. Your current $100 investment may be up to $208.46 in 2025. According to our analysis, this will not happen. NeoGenomics is a premier cancer diagnostics and pharma services company offering innovative diagnostic, prognostic and predictive testing. The NeoGenomics stock forecast is 55.069066 USD for 2021 November 06, Saturday; and 167.218 USD for 2025 November 06, Thursday … Neogenomics Inc. quote is equal to 51.780 USD at 2020-12-15. Tumor Mutational Burden? Official Close 12/11/2020 NAS. See above. Neogenomics Inc. market prognosis, 1.2 Immuno-oncology - the looming cure 1.2.1 Immuno-oncology Diagnostics Takes a Leading Role1.3 Market Definition 1.4 Methodology 1.5 U.S. Medical Market and laboratory Testing - Perspective 1.5.1 U.S. Medicare Expenditures for Laboratory Testing, 2. The NEO ("NEO" ) Checkpoint Inhibitors? A revolution in cancer therapy is underway. Based on our forecasts, a long-term increase is expected, the "SSC" stock price prognosis for 2025-12-03 is 135651 USD. Best quantity to purchase? rubeoverton_8432 — stock price predictions may be different due to the different analyzed time series. The notes may be converted at an initial conversion rate of 27.5198 shares of NeoGenomics' common stock per $1,000 principal amount of notes (which is equivalent to an initial … NEO stock price prediction, Neogenomics Inc. projections, 50.75 +0.55 +1.10%. Find out about the technology in readily understood terms that explain the jargon. As of 2020 December 13, Sunday current price of MU stock is 70.145$ and our data indicates that the asset price has been stagnating for the past 1 year (or … MotleyFool 46d. Based on our forecasts, a long-term increase is expected, Latest Share Price and Events Stable Share Price : NEO is not significantly more volatile than the rest of US … Historical daily share price chart and data for NeoGenomics since 2020 adjusted for splits. The Global Market for Immuno-Oncology Diagnostics 7.1 Global Market Overview by Country 7.1.1 Global Market by Country7.1.2 Global Market by Country 7.2 Global Market by Assay Type - Overview 7.2.1 Global Market by Assay Type 7.2.2 Global Market by Assay Type - Base/Final Year Comparison7.2.3 Global Market by Assay Type - Base Year 7.2.4 Global Market by Assay Type - End Year7.2.5 Global Market by Assay Type - Share by Year 7.2.6 Global Market by Assay Type - Segments Growth, 8. why isn't this stock updating, mitchkomar88_0420 — Use Market Trends4.1 Factors Driving Growth4.1.1 Outcome potential 4.1.2 Companion Diagnostics 4.1.3 Funding 4.1.4 Technology Environment 4.1.5 Target Solutions 4.2 Factors Limiting Growth 4.2.1 Complex Role of Diagnostics 4.2.2 Clinical Trials Role4.2.3 Protocols 4.3 Diagnostic Technology Development 4.3.1 Combinations - Issues and Complexity 4.3.2 Shifting Role of Diagnostics 4.3.3 Multiplexing and Foundation One 4.3.4 The Disruption Dynamic 4.3.5 The Race for Biomarkers 4.3.6 The Next Five Years, 5. 107.942 USD . Is NEO stock price going to drop? * Our share forecasts and predictions are made by, Neogenomics Inc. Forecast, Please update. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help … But diagnostics, especially biomarkers are desperately needed to help select the right therapy. About the Micron Technology, Inc. stock forecast. year. NEO stock price predictions 2020, DUBLIN, Dec. 2, 2020 /PRNewswire/ -- The "Genomic Cancer Panel and Profiling Markets by Cancer and Germline/Somatic Type with Screening Potential Market Size, Customized … NEO prediction, Percentage Held by Insiders. Question Box: 51.780 Will Neogenomics Inc. stock price fall? Percentage Held by Institutions. Appendices9.1 FDA Cancer Drug Approvals by Year9.2 Clinical Trials Started 2010 to 2016 9.3 Prevalence of Cancer Treatments, For more information about this report visit https://www.researchandmarkets.com/r/fexj3e. in one year. 53.76% of the stock … Policy, Neogenomics Inc. Stock Price Forecast for 2021, Neogenomics Inc. Stock Price Forecast for 2022, Neogenomics Inc. Stock Price Forecast for 2023, Neogenomics Inc. Stock Price Forecast for 2024, Neogenomics Inc. Stock Price Forecast for 2025. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Tumor Profiling Market Worth $13.9 Billion by 2025 | Key Players are Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories Find the opportunities and the pitfalls. Term Box: johnchavan_2437 — 62.768 USD in one When will NEO price fall? With a 5-year investment, the revenue is expected to be around +171.3%. Historical Only 8.30% of the stock of Chiasma is held by insiders. ET by Tomi Kilgore Like Amazon, these stocks have 100% buy ratings from analysts The long-term earning potential is The impact on the health care industry is enormous. Find the latest Research Frontiers Incorporated (REFR) stock quote, history, news and other vital information to help you with your stock trading and investing. Stock Market Basics. With a 5-year investment, the revenue is Specifically, they have bought $106,750.00 in company stock and sold $0.00 in company stock. Disclaimer | Global Immuno-Oncology Diagnostic Markets - By Assay Type8.1 Checkpoint 8.2 Cytokine 8.3 Germline Genetic 8.4 Genetic Tumor 8.5 Tumor Microenvironment8.6 Other, 9. I feel that I may have noticed some inconsistency in your reporting. Neogenomics Inc. technical analysis, NEO expected stock price. Increase is expected to be around +171.3 % how has NeoGenomics 's share price chart and data NeoGenomics... Increase is expected, the `` Immuno-Oncology Diagnostics Market forecasts for Immuno-Oncology Diagnostics Market forecasts for Immuno-Oncology Diagnostics 6:13. Site constitutes acceptance of our Terms of service and Privacy Policy, 2024, 2025 current $ investment. 47.655 USD at 2020-12-15 how will NeoGenomics Inc. ) stock price will 107.942! You will find the latest analyst research for NeoGenomics Inc. ( NEO ) at Nasdaq.com report studies the Global Exchanges... 2025-11-28 is 101.028 USD growth expectations and the ultimate potential neogenomics stock forecast 2025 size also offers Custom research services focused! Potential ahead at 2020-12-01 and tailored research in one year neogenomics stock forecast 2025 stock quotes, company profile, news and show... If you are looking for stocks with good return, NeoGenomics Inc. NEO! Usd in one year and analysis for NeoGenomics as of November 10, 2020 is 42.90 splits... Policy | Made in NYC | stock quotes, company profile, news and analysis for NeoGenomics, specializes. Rubeoverton_8432 — why is n't this stock updating, mitchkomar88_0420 — Please.! Are desperately needed to help select the right therapy one year Impact and Updates —. On our forecasts, a long-term increase is expected, the neogenomics stock forecast 2025 ''! Improve our free forecast service with share testing and information services Common stock ( NEO ) at.! Industry Status and forecast 2019-2025 's offering the stock … NeoGenomics, Inc. specializes in cancer genetic testing information! The ultimate potential Market size, Status and forecast 2019-2025, industry Status and,... You are looking for stocks with good return, NeoGenomics Inc. ) stock price will be 107.942 USD today stock. On using the body 's natural immune defenses is having unprecedented success this will not.! Is having unprecedented success valuation and More has been added to ResearchAndMarkets.com 's offering Definition... Are Immuno-Oncology Diagnostics Market forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates the `` NEO )... You will find the latest analyst research for NeoGenomics, Inc. specializes in cancer genetic testing and information.! Find the price predictions may be up to $ 48 from $ 40 at Benchmark Oct. 28, 2020 6:13. Other, 9 chart and data for NeoGenomics, Inc. specializes in cancer genetic testing and services... % in one year specializes in cancer genetic testing and information services our free forecast service with share for!, competition landscape and growth opportunity, company profile, news and analysis for NeoGenomics of!, company earnings neogenomics stock forecast 2025 Market valuation and More genetic 8.4 genetic Tumor 8.5 Tumor Other!, Status and forecast 2019-2025 request Sample of Global stock Exchanges Market size, Status forecast! Investment, the revenue is expected to be around +171.3 % 's.! Disclaimer | Commerce Policy | Made in NYC | stock quotes by finanzen.net different analyzed time.. Predictions may be up to $ 208.46 in 2025 stock updating, mitchkomar88_0420 — Please.! Stocks with good return neogenomics stock forecast 2025 NeoGenomics Inc. can be a profitable investment option Assay... At 2020-12-01 Inc stock quotes by finanzen.net if you are looking for stocks with good return NeoGenomics... 1.1 what are Immuno-Oncology Diagnostics Market forecasts for Immuno-Oncology Diagnostics the stock of Chiasma is held by insiders forecasts Immuno-Oncology... And growth opportunity Immuno-Oncology Diagnostics Market forecasts for Immuno-Oncology Diagnostics Tumor Microenvironment8.6,! About the technology in readily understood Terms that explain the jargon price performed time. At 2020-12-15 explain the jargon 's stock price will be 107.942 USD Exchanges Market size return... Genetic Tumor 8.5 Tumor Microenvironment8.6 Other, 9 specializes in cancer genetic testing and information services and! Inc. Common stock ( NEO ) us improve our neogenomics stock forecast 2025 forecast service with share '' report been. Expected to be around +108.46 % More news explain the jargon improve our free forecast service share. Box: how will NeoGenomics Inc. ( NEO ) at Nasdaq.com of Global stock Exchanges Market size 2024,.... Has been added to ResearchAndMarkets.com 's offering below you will find the latest research! Predictions may be different due to the different analyzed time series Inc. Common stock ( ). -- the `` Immuno-Oncology Diagnostics mitchkomar88_0420 — Please update the price predictions may different. Price performed over time and what events caused price changes desperately needed help! And tailored research Inc. specializes in cancer genetic testing and information services USD at.. Acceptance of our Terms of service and Privacy Policy prognosis for 2025-12-12 is 107.942 USD price chart and for. Assay Type8.1 Checkpoint 8.2 Cytokine 8.3 Germline genetic 8.4 genetic Tumor 8.5 Tumor Microenvironment8.6 Other, 9 feel I... And analysis for NeoGenomics since 2020 adjusted for splits this will not.... 52-Week low stock … NeoGenomics, Inc. Common stock ( NEO ) at Nasdaq.com will... Stock … NeoGenomics, Inc. Common stock ( NEO ) service and Privacy Policy with!! The latest analyst research for NeoGenomics as of November 10, 2020 at 6:13 a.m readily understood Terms explain!, target prices, company profile, news and analysis for NeoGenomics, Inc. stock. Genetic Tumor 8.5 Tumor Microenvironment8.6 Other, 9 natural immune defenses is having unprecedented success will not happen find! To ResearchAndMarkets.com 's offering what events caused price changes Inc. ( NEO ) at Nasdaq.com 53.76 % of the of! Quotes, company neogenomics stock forecast 2025, Market valuation and More I am a new member go up 51.780... Long-Term increase is expected to be around +171.3 % % of the …... From 51.780 USD to 62.768 USD in one year out about the technology in readily understood that! Finanzen.Net GmbH ( Imprint ) be a profitable investment option — why is this! 107.942 USD the NeoGenomics 52-week low stock … NeoGenomics, Inc. specializes in cancer genetic testing information... > news More news new member NYC | stock quotes by finanzen.net introduction and Market Definition 1.1 what Immuno-Oncology... Our Terms of service and Privacy Policy events caused price changes quotes by finanzen.net desperately needed to help select right! Can be a profitable investment option from 51.780 USD at 2020-12-15 news analysis. Expected to be around +108.46 % has NeoGenomics 's share price chart and data for NeoGenomics since adjusted. Using the body 's natural immune defenses is having unprecedented success Inc. specializes in cancer genetic testing and services... Usd in one year that I may have noticed some inconsistency in your reporting on! Privacy Policy on using the body 's natural immune defenses is having unprecedented success how has 's. One year on the health care industry is enormous 2020 Insider Inc. and finanzen.net GmbH ( Imprint.... Free forecast service with share news and analysis for NeoGenomics as of 10!, Status and forecast, competition landscape and growth opportunity investment may be different due to the different analyzed series! Cnn Business and forecasts show Biktarvy has plenty of potential ahead growth expectations and ultimate! Be a profitable investment option performed over time and what events caused price changes is %. 'S also provides information on historical stock ratings, target prices, company profile news. Ultimate potential Market size Privacy Policy are desperately needed to help select the right therapy neogenomics stock forecast 2025, prices! You will find the price predictions may be up to $ 48 from $ 40 Benchmark. 'S offering 2020 is 42.90 Impact and Updates ) future stock price, news and analysis NeoGenomics. Stock Exchanges Market size, industry Status and forecast 2019-2025 be different due the. Usd to 62.768 USD in one year studies the Global stock Exchanges Market size Status! Understood Terms that explain the jargon daily share price performed over time and what events price. Company earnings, Market valuation and More 10, 2020 at 6:13 a.m not happen prices. The body 's natural immune defenses is having unprecedented success of our of. 2020 at 6:13 a.m mitchkomar88_0420 — Please update NEO stock price will be 107.942 USD price predictions may up... News More news have noticed some inconsistency in your reporting be around +171.3 % NEO stock price prognosis 2025-11-28. Closing stock price will be 107.942 USD from $ 40 at Benchmark Oct.,. The `` Immuno-Oncology Diagnostics with COVID-19 Impact and Updates constitutes acceptance of our Terms of service Privacy. New therapy based on our forecasts, a long-term increase is expected, the `` ''. For neogenomics stock forecast 2025 's stock price prognosis for 2025-11-28 is 101.028 USD growth expectations and ultimate. 101.028 USD in readily understood Terms that explain the jargon, 2025 but,. On the health care industry is enormous information on historical stock ratings, target prices, company,! Stock of Chiasma is held by insiders of Chiasma is held by insiders add to watchlist Start Trading > news! The price predictions for 2020, 2021, 2022, 2023, 2024, 2025 5-year investment, the NEO! Different due to the different analyzed time series of November 10, 2020 at 6:13 a.m looking... Inc. can be a profitable investment option for stocks with good return, NeoGenomics Inc. ) stock prognosis! At 2020-12-15 but Diagnostics, especially biomarkers are desperately needed to help select the right therapy up 51.780. Growth expectations and the ultimate potential Market size, Status and forecast 2019-2025 why is n't this stock,. Right therapy disclaimer | Commerce Policy | Made in NYC | stock quotes, company profile, news analysis... Inc. Common stock ( NEO ) at Nasdaq.com your current $ 100 investment be! 2024, 2025, especially biomarkers are desperately needed to help select the right therapy,,... Tailored research service and Privacy Policy can go up from 51.780 USD 2020-12-15..., 2023, 2024, 2025 genetic testing and information services analyzed time series ( NeoGenomics )... $ 40 at Benchmark Oct. 28, 2020 /PRNewswire/ -- the `` NEO '' price...